Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.04 (+4.94%)
At close: Aug 19, 2026 · 3:30 PM UTC

Cresco Labs (CRLBF) Income towards Parent Company (2020 - 2026)

Cresco Labs' (CRLBF) quarterly Income towards Parent Company came in at -$13.3 million in Q1 2026, up 8.04% YoY from -$12.3 million in Q1 2025, and up 84.45% on a QoQ basis from -$85.3 million in Q4 2025.

Cresco Labs (CRLBF) Income towards Parent Company (2020 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 7 years of Income towards Parent Company data on file, last reported at -$13.3 million in Q1 2026.

  • Quarterly Income towards Parent Company rose 8.04% year-over-year to -$13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$132.2 million (down 79.26% YoY) and the FY2025 annual result came in at -$140.0 million, down 131.52% from the prior year.
  • Income towards Parent Company grew to -$13.3 million in Q1 2026, from -$85.3 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $27.4 million in Q1 2022 to a low of -$161.3 million in Q4 2022.
  • A 5-year average of -$32.0 million and a median of -$14.4 million in 2025 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2024 — Income towards Parent Company jumped 115.22% — and 2025, when it slumped 1604.87%.
  • Tracing CRLBF's Income towards Parent Company over 5 years: stood at -$161.3 million in 2022, then soared by 101.63% to $2.6 million in 2023, then soared by 115.22% to $5.7 million in 2024, then tumbled by 1604.87% to -$85.3 million in 2025, then jumped by 84.45% to -$13.3 million in 2026.
  • The last three Income towards Parent Company figures came in at -$13.3 million (Q1 2026), -$85.3 million (Q4 2025), and -$17.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.87 Bn 42.91 Bn -
2 Teva Pharmaceutical Industries 43.00 Bn 39.35 Bn 2.15 Bn
3 Zoetis 31.59 Bn 29.92 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn
7 Neurocrine Biosciences 15.55 Bn 15.16 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn -
10 Cresco Labs 292.94 Mn 228.83 Mn 86.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.27 Mn
Dec 31, 2025 -85.34 Mn
Sep 30, 2025 -17.29 Mn
Jun 30, 2025 -16.33 Mn
Mar 31, 2025 -14.43 Mn
Dec 31, 2024 5.67 Mn
Sep 30, 2024 -10.54 Mn
Jun 30, 2024 -54.46 Mn
Mar 31, 2024 -5.51 Mn
Dec 31, 2023 2.64 Mn
Sep 30, 2023 -115.57 Mn
Jun 30, 2023 -36.53 Mn
Mar 31, 2023 -26.05 Mn
Dec 31, 2022 -161.34 Mn
Sep 30, 2022 -9.79 Mn
Jun 30, 2022 -13.54 Mn
Mar 31, 2022 27.38 Mn
Dec 31, 2021 -624.46 Mn
Sep 30, 2021 -270.65 Mn
Jun 30, 2021 4.83 Mn